[TOP STORY] GLP-1: A threat to fast-food and associated medical intervention businesses?

Loading player...
Ross Yammin from Laurium Capital dips into the opportunities and threats possibly posed by Novo and Lilly’s ‘wonder’ drug.
8 Mar 2024 2AM English South Africa Business News · Business

Other recent episodes

AB Inbev: A mature stock but priced for growth

Carmen Mpelwane unpacks AB InBev’s rising profits despite falling beer sales. David Lloyd of King Alexander Investments introduces a fresh take on LISPs with flat fees and guarantees. Plus, Simon weighs in on subscription fatigue – are we paying too much for too many?
9 May 1AM 20 min

Strong Palantir results, but valuations worry investors

Independent analyst Jimmy Moyaha unpacks Palantir Technologies — strong results and raised guidance, but the stock still tumbled over 10%. Tasneem Samodien of Old Mutual Private Wealth looks into Estée Lauder’s dramatic 80% decline. What went wrong, and is there value to be found or reason to steer clear? Michael…
8 May 1AM 20 min